{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:04:08Z","timestamp":1768313048846,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T00:00:00Z","timestamp":1489449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.omtm.2017.03.002","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T15:34:37Z","timestamp":1489851277000},"page":"51-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Viral Vector-Based Innovative Approaches to Directly Abolishing Tumorigenic Pluripotent Stem Cells for Safer Regenerative Medicine"],"prefix":"10.1016","volume":"5","author":[{"given":"Kaoru","family":"Mitsui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Ide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichiro","family":"Kosai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2017.03.002_bib1","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.cell.2016.05.043","article-title":"Stem Cells: A Renaissance in Human Biology Research","volume":"165","author":"Wu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2017.03.002_bib2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrm.2016.10","article-title":"Pluripotent stem cells progressing to the clinic","volume":"17","author":"Trounson","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtm.2017.03.002_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2016.245","article-title":"Induced pluripotent stem cell technology: a decade of progress","volume":"16","author":"Shi","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtm.2017.03.002_bib4","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm.3267","article-title":"Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies","volume":"19","author":"Lee","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2017.03.002_bib5","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMra032207","article-title":"Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency","volume":"350","author":"McCormack","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2017.03.002_bib6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2014.01.005","article-title":"Premature termination of reprogramming in\u00a0vivo leads to cancer development through altered epigenetic regulation","volume":"156","author":"Ohnishi","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2017.03.002_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.stem.2013.12.005","article-title":"Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics","volume":"14","author":"Chen","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2017.03.002_bib8","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1089\/hum.1998.9.9-1293","article-title":"Retrovirus-mediated in\u00a0vivo gene transfer in the replicating liver using recombinant hepatocyte growth factor without liver injury or partial hepatectomy","volume":"9","author":"Kosai","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2017.03.002_bib9","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1158\/1078-0432.CCR-03-0275","article-title":"A definitive role of RhoC in metastasis of orthotopic lung cancer in mice","volume":"10","author":"Ikoma","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtm.2017.03.002_bib10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ymthe.2006.05.010","article-title":"Identification and isolation of embryonic stem cell-derived target cells by adenoviral conditional targeting","volume":"14","author":"Takahashi","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2017.03.002_bib11","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1128\/MCB.01293-14","article-title":"Retroviral transcriptional regulation and embryonic stem cells: war and peace","volume":"35","author":"Schlesinger","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.omtm.2017.03.002_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/B978-0-12-386509-0.00003-X","article-title":"Retrovirus and lentivirus vector design and methods of cell conditioning","volume":"507","author":"Cooray","year":"2012","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.omtm.2017.03.002_bib13","doi-asserted-by":"crossref","first-page":"13781","DOI":"10.1073\/pnas.0806976105","article-title":"Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors","volume":"105","author":"Suzuki","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2017.03.002_bib14","doi-asserted-by":"crossref","first-page":"15026","DOI":"10.1038\/mtm.2015.26","article-title":"Conditionally replicating adenovirus prevents pluripotent stem cell-derived teratoma by specifically eliminating undifferentiated cells","volume":"2","author":"Mitsui","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2017.03.002_bib15","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jhep.2005.10.027","article-title":"In\u00a0vivo hepatic HB-EGF gene transduction inhibits Fas-induced liver injury and induces liver regeneration in mice: a comparative study to HGF","volume":"44","author":"Khai","year":"2006","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtm.2017.03.002_bib16","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1073\/pnas.92.7.2577","article-title":"Combination gene therapy for liver metastasis of colon carcinoma in\u00a0vivo","volume":"92","author":"Chen","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2017.03.002_bib17","first-page":"3758","article-title":"Combination suicide and cytokine gene therapy for hepatic metastases of colon carcinoma: sustained antitumor immunity prolongs animal survival","volume":"56","author":"Chen","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtm.2017.03.002_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/jhep.2003.50018","article-title":"An optimal therapeutic expression level is crucial for suicide gene therapy for hepatic metastatic cancer in mice","volume":"37","author":"Terazaki","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2017.03.002_bib19","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1016\/j.biomaterials.2012.01.023","article-title":"Protecting against wayward human induced pluripotent stem cells with a suicide gene","volume":"33","author":"Cheng","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.omtm.2017.03.002_bib20","doi-asserted-by":"crossref","first-page":"16069","DOI":"10.1038\/mtm.2016.69","article-title":"Elimination of proliferating cells from CNS grafts using a Ki67 promoter-driven thymidine kinase","volume":"6","author":"Tieng","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2017.03.002_bib21","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/mt.2015.100","article-title":"An Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells","volume":"23","author":"Yagyu","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2017.03.002_bib22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.stemcr.2015.07.011","article-title":"A\u00a0Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy","volume":"5","author":"Ando","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.omtm.2017.03.002_bib23","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/sj.gt.3302540","article-title":"An efficient construction of conditionally replicating adenoviruses that target tumor cells with multiple factors","volume":"12","author":"Nagano","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2017.03.002_bib24","doi-asserted-by":"crossref","first-page":"16018","DOI":"10.1038\/mtm.2016.18","article-title":"Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses","volume":"3","author":"Ungerechts","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2017.03.002_bib25","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1158\/0008-5472.CAN-04-2657","article-title":"Survivin-responsive conditionally replicating adenovirus exhibits cancer-specific and efficient viral replication","volume":"65","author":"Kamizono","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtm.2017.03.002_bib26","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/cgt.2011.44","article-title":"Assessment of an altered E1B promoter on the specificity and potency of triple-regulated conditionally replicating adenoviruses: implications for the generation of ideal m-CRAs","volume":"18","author":"Horikawa","year":"2011","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.omtm.2017.03.002_bib27","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/1535-7163.MCT-05-0375","article-title":"Survivin, a cancer target with an emerging role in normal adult tissues","volume":"5","author":"Fukuda","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.omtm.2017.03.002_bib28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/mt.2009.262","article-title":"A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors","volume":"18","author":"Nemunaitis","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2017.03.002_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1479-5876-12-27","article-title":"Survivin-responsive conditionally replicating adenovirus kills rhabdomyosarcoma stem cells more efficiently than their progeny","volume":"12","author":"Tanoue","year":"2014","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.omtm.2017.03.002_bib30","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/sj.gt.3302005","article-title":"Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells","volume":"10","author":"Yang","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2017.03.002_bib31","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1080\/13550280802348214","article-title":"Tumor-specific activity of cellular regulatory elements is down-regulated upon insertion into the herpes simplex virus genome","volume":"14","author":"Glass","year":"2008","journal-title":"J.\u00a0Neurovirol."},{"key":"10.1016\/j.omtm.2017.03.002_bib32","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cmet.2014.03.017","article-title":"Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells","volume":"19","author":"Shiraki","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.omtm.2017.03.002_bib33","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.stemcr.2015.02.016","article-title":"Elimination of tumorigenic human pluripotent stem cells by a recombinant lectin-toxin fusion protein","volume":"4","author":"Tateno","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.omtm.2017.03.002_bib34","doi-asserted-by":"crossref","first-page":"32532","DOI":"10.1038\/srep32532","article-title":"MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells","volume":"6","author":"Parr","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050117300475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050117300475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T07:27:52Z","timestamp":1535959672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050117300475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":34,"alternative-id":["S2329050117300475"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2017.03.002","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viral Vector-Based Innovative Approaches to Directly Abolishing Tumorigenic Pluripotent Stem Cells for Safer Regenerative Medicine","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2017.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s).","name":"copyright","label":"Copyright"}]}}